The global monoclonal antibody diagnostic reagent market is witnessing rapid expansion, driven by the increasing demand for precise and early disease detection technologies. The market is projected to grow from US$12.82 billion in 2025 to US$41.02 billion by 2034 , registering a robust CAGR of 13.79% during 2026–2034.
Monoclonal antibody (mAb) diagnostic reagents play a critical role...
The global CHST15 antibody market is gaining significant momentum due to the increasing focus on cancer research, molecular diagnostics, and targeted therapeutic development. CHST15 antibodies are widely utilized in biomedical research to study carbohydrate sulfotransferase 15 expression and its role in tumor progression, fibrosis, and inflammatory diseases. Growing investments in biotechnology...
About SPORTIVO Network
Czech
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek